Hypertension Caused by Transgenic Overexpression of Rac1
- 1 January 2007
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 9 (1) , 91-100
Abstract
Reactive oxygen species, including superoxide, are important mediators of the pathophysiology of hypertension. In the vasculature, superoxide antagonizes nitric oxide (NO•), resulting in increased vascular tone. The GTP binding protein Rac regulates a wide variety of cellular functions, including the activation of NADPH oxidase, the major source of O2•− in the blood vessel wall. An hypothesis is that Rac1 may act as an important regulator of vascular O2•− production, contributing to the balance between O2•− and NO• and maintaining consequent homeostasis of blood pressure. To alter the activity of vascular NADPH oxidase, the authors developed a transgenic animal model that overexpresses the human cDNA of the constitutively active mutant of Rac1 (RacCA) in smooth muscle cells using the smooth muscle ±-actin promoter. The RacCA transgenic had excessive amounts of O2•− in the vessel wall that, which led to heightened production of peroxynitrite, as detected by increased protein nitration and reduced NO• levels. RacCA mice developed moderate hypertension, which was corrected by N-acetyl-L-cysteine (NAC). RacCA transgenic mice also developed left ventricular hypertrophy as a secondary effect of pressure overload. The data suggest that Rac1 is a critical regulator of the redox state of blood vessels and homeostasis of blood pressure.Keywords
This publication has 31 references indexed in Scilit:
- Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertensionClinical Science, 2006
- Smooth muscle cell expression of a constitutive active form of human Rac 1 accelerates cutaneous wound repairSurgery, 2005
- Chronic N-Acetylcysteine Administration Prevents Development of Hypertension in N.OMEGA.-Nitro-L-Arginine Methyl Ester-Treated Rats: The Role of Reactive Oxygen SpeciesHypertension Research, 2005
- Workshop:Hypertension and Cardiovascular Risk FactorsHypertension, 2001
- Pharmacoeconomic Considerations in the Management of HypertensionDrugs, 2000
- Endothelial Function in HypertensionHypertension, 1999
- The Molecular Basis of HypertensionAnnual Review of Biochemistry, 1999
- The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1992
- A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophagesFEBS Letters, 1992
- Developmental patterns of PDGF B-chain, PDGF-receptor, and α-actin expression in human glomerulogenesisKidney International, 1992